节点文献

狗血浆中哌唑嗪的含量测定方法及其在药代动力学中的应用(英文)

Method for quantification of prazosin in dog plasma and its application to pharmacokinetic study

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张妮萍余书勤王辉申艳艳徐师张玲许茜

【Author】 Zhang Niping1 Yu Shuqin2 Wang Hui2 Shen Yanyan1,3 Xu Shi1 Zhang Ling1 Xu Qian1,3(1 Ministry of Education Key Laboratory of Environmental Medicine and Engineering,Southeast University,Nanjing 210009,China)(2 Jiangsu Key Laboratory for Medical Supermolecule Material and Application,Nanjing Normal University,Nanjing 210046,China)(3 Suzhou Key Laboratory of Environment and Biosafety,Suzhou Institute,Southeast University,Suzhou 215123,China)

【机构】 东南大学环境医学工程教育部重点实验室南京师范大学江苏省医药超分子及应用重点实验室东南大学苏州研究院苏州市环境与生物安全重点实验室

【摘要】 建立并评价了一种简单灵敏的方法测定狗血浆中PZS的含量.该方法利用HPLC-FLD结合乙醚萃取的前处理方法,采用C18色谱柱(150mm×4.6mm,5μm),流动相为30%乙腈和70%乙酸-乙酸钠缓冲液(pH=3.6),荧光检测器的激发波长为258nm,发射波长为387nm,在流动相流速为1.0mL/min时,其PZS和内标物的保留时间分别为4.4和5.8min.标准曲线在1.0~1000.0ng/mL的浓度范围内呈线性相关(r2>0.998),检出限为0.4ng/mL,标准曲线的日间变异系数低于5.0%,准确度在92.7%~104.2%范围内.在3d的分析质量控制研究中,日内和日间精密度均小于10%,准确度为95.9%~112.7%.该方法成功应用于一种新的口服制剂(PZS-磺丁基醚-β-环糊精包合物)的临床前期药代动力学评价,结果表明:该新型的包合药物具有缓释PZS的功效,且其相对生物利用率为105.0%.

【Abstract】 A simple and sensitive high performance liquid chromatography method using fluorescence detection(HPLCFLD) and a one-step single solvent extraction for the determination of prazosin(PZS) in dog plasma is developed and validated.After extraction with ether,the chromatographic separation of PZS is carried out using a reverse phase C18 column(150 mm×4.6 mm,5 μm) with a mobile phase of 30% acetonitrile and 70% acetic acid-sodium acetate buffer solution(pH = 3.6) and quantified by fluorescence detection operated with an excitation wavelength of 258 nm and an emission wavelength of 387 nm.The flow rate of the mobile phase is 1.0 mL /min and the retention time of PZS and the internal standard is found to be 4.4 and 5.8 min,respectively.The calibration curve is linear within a concentration range from 1.0 to 1 000.0 ng /mL(r2 > 0.998).The limit of detection is 0.4 ng /mL.The inter-day coefficient of variation(COV) of the calibration standards is below 5.0% and the mean accuracy is in the range from 92.7% to 104.2%.Moreover,by analyzing quality control plasma samples for three days,the results show that the method is precise and accurate,for the intra-and interday COV within 10% and the accuracy from 95.9% to 112.7%.The developed and validated method is successfully applied to pharmacokinetic study for the preclinical evaluation of a new peroral PZS-sulfobutyl ether beta-cyclodextrin(PZS-SBE-βCD) inclusion complex tablets(test preparation),which demonstrates that the test preparation released PZS is conducted in a slow and controlled way,and the relative bioavailability of the test preparation is found to be 105.0%.

【基金】 Pre-Research Foundation for the National Natural Science Foundation of Southeast University(No.9225000007);Suzhou Science and Technology Development Projects(No.YJS0948)
  • 【文献出处】 Journal of Southeast University(English Edition) ,东南大学学报(英文版) , 编辑部邮箱 ,2011年02期
  • 【分类号】R96;O657.72
  • 【下载频次】133
节点文献中: 

本文链接的文献网络图示:

本文的引文网络